I am an Associate Professor at the Department of Psychiatry at the University of California San Diego (UCSD), and the Department of Medicine, Division of Genetic Medicine at Vanderbilt University Medical Center (VUMC). I have been working in the area of psychiatric genetics, and particularly substance use disorders, for over 15 years. I currently have 71 publications, published in top tier journals (Nature Genetics, Nature Neuroscience, American Journal of Psychiatry, Biological Psychiatry, Molecular Psychiatry), and I am an active member of many professional societies and international consortiums (PsycheMERGE, Externalizing, Latin American Genomics Consortium, Psychiatric Genomics Consortium). My work is focused on understanding causal factors contributing to psychiatric disorders, particularly substance use disorders and conditions characterized by high levels of impulsivity. In the past, I used behavioral and pharmacological experiments and molecular analysis to address this question, with special emphasis on translational validity to human studies. My current research focuses on the quantitative analysis of complex traits in humans using data from industry partners and academic initiatives, and translating some of the research findings in mouse and rat models. In parallel, I also use big data and high-throughput phenotyping to advance precision medicine by using electronic health records, leveraging access to one of the largest biobanks in the US from VUMC (BioVU) and collaborations within members of the PsycheMERGE consortium. Since becoming faculty at UCSD, I received a total of 10 grants (7 active, 3 closed; 6 as sole PI) in a 3 year-period (2019-2022), totaling >$4.3M (direct costs). Over the next decade, I seek to integrate the oceans of data generated (and continually expanding!) by human genetics research with data from electronic health records and model organisms, with the goal of furthering our biological understanding of psychiatric disorders and bringing the most promising results to the clinic.